CCM
LH icon

Cloverdale Capital Management’s Labcorp LH Stock Holding History

Cloverdale Capital Management’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-101,183
Closed -$12.5M – 13
2017
Q1 		$12.5M Buy
101,183
+4,571
+5% +$541K 7.54% 5
2016
Q4 		$10.7M Buy
+96,612
New +$10.7M 8.54% 7

Other funds holding LH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Cloverdale Capital Management's LH Position: Q2 2017 in Review

Cloverdale Capital Management sold out of Labcorp (LH) in Q2 2017, closing a stake of 101,183 shares — an estimated $12.5M sold.

Cloverdale Capital Management first reported a position in LH in Q4 2016 and held it in 2 quarters. The position peaked at $12.5M in Q1 2017. 691 funds tracked by Wall St. Rank hold LH as of Q2 2017.

  • Cloverdale Capital Management reported no remaining Labcorp position as of Q2 2017 after selling out during the quarter.
  • Cloverdale Capital Management sold 101,183 Labcorp shares in Q2 2017, an estimated $12.5M.
  • Cloverdale Capital Management first reported a position in Labcorp in Q4 2016 and held it in 2 quarters.
  • Cloverdale Capital Management's Labcorp position peaked at $12.5M in Q1 2017.
  • 691 funds tracked by Wall St. Rank held Labcorp as of Q2 2017.

Based on Cloverdale Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.